Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 20, 2020

SELL
$47.45 - $62.95 $42,325 - $56,151
-892 Closed
0 $0
Q1 2020

Apr 28, 2020

SELL
$41.6 - $63.4 $7,737 - $11,792
-186 Reduced 17.25%
892 $42,000
Q4 2019

Jan 23, 2020

BUY
$53.85 - $65.27 $49,165 - $59,591
913 Added 553.33%
1,078 $65,000
Q3 2019

Nov 06, 2019

BUY
$59.06 - $72.15 $9,744 - $11,904
165 New
165 $10,000
Q1 2018

Apr 30, 2018

SELL
$44.08 - $55.05 $23,362 - $29,176
-530 Closed
0 $0
Q4 2017

Feb 01, 2018

BUY
$50.3 - $64.39 $26,659 - $34,126
530
530 $27,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.1B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Harel Insurance Investments & Financial Services Ltd. Portfolio

Follow Harel Insurance Investments & Financial Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.